APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lyme Disease Testing

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lyme Disease Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

6 January 2026190 pages

Choose your research edition.

Industry ResearchLyme Disease Testing Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Lyme Disease Testing Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Lyme Disease Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lyme Disease Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lyme Disease Testing Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Lyme Disease Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Lyme Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lyme Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lyme Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lyme Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lyme Disease Testing include Quidel Corporation, Roche Holding AG, Fujirebio(H.U. Group Holdings), ZEUS Scientific, IGeneX, Thermo Fisher Scientific, Everlywell, Oxford Immunotec Global PLC(PerkinElmer) and BioMerieux, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Lyme Disease Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lyme Disease Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lyme Disease Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Lyme Disease Testing market size, projected growth trends, production technologies, key applications, and end-use industries.

Lyme Disease Testing Segment by Company

Quidel Corporation

Roche Holding AG

Fujirebio(H.U. Group Holdings)

ZEUS Scientific

IGeneX

Thermo Fisher Scientific

Everlywell

Oxford Immunotec Global PLC(PerkinElmer)

BioMerieux

Bio-Rad Laboratories

T2 Biosystems

Lyme Disease Testing Segment by Type

ELISA

Western Blotting

PCR

Others

Lyme Disease Testing Segment by Application

Hospital and Testing Agency

Personal

Lyme Disease Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lyme Disease Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lyme Disease Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lyme Disease Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Lyme Disease Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lyme Disease Testing industry.

Chapter 3: Detailed analysis of Lyme Disease Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lyme Disease Testingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lyme Disease Testing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of ELISA Table 3. Key Players of Western Blotting Table 4. Key Players of PCR Table 3. Key Players of Others Table 4. Global Lyme Disease Testing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital and Testing Agency Table 6. Key Players of Personal Table 7. Global Lyme Disease Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Lyme Disease Testing Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Lyme Disease Testing Market Share by Region (2021-2026) Table 10. Global Lyme Disease Testing Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Lyme Disease Testing Market Share by Region (2027-2032) Table 12. Lyme Disease Testing Industry Trends Table 13. Lyme Disease Testing Industry Drivers Table 14. Lyme Disease Testing Industry Opportunities and Challenges Table 15. Lyme Disease Testing Industry Restraints Table 16. Global Lyme Disease Testing Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Lyme Disease Testing Revenue Market Share by Company (2021-2026) Table 18. Global Lyme Disease Testing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Lyme Disease Testing Key Company Head Office and Area Served Table 20. Global Lyme Disease Testing Company, Product Type & Application Table 21. Global Lyme Disease Testing Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Lyme Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Lyme Disease Testing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lyme Disease Testing Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Lyme Disease Testing Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Lyme Disease Testing Revenue Market Share by Type (2021-2026) Table 28. Global Lyme Disease Testing Revenue Market Share by Type (2027-2032) Table 29. Global Lyme Disease Testing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Lyme Disease Testing Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Lyme Disease Testing Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Lyme Disease Testing Revenue Market Share by Application (2021-2026) Table 33. Global Lyme Disease Testing Revenue Market Share by Application (2027-2032) Table 34. Quidel Corporation Company Information Table 35. Quidel Corporation Business Overview Table 36. Quidel Corporation Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Quidel Corporation Lyme Disease Testing Product Portfolio Table 38. Quidel Corporation Recent Development Table 39. Roche Holding AG Company Information Table 40. Roche Holding AG Business Overview Table 41. Roche Holding AG Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Roche Holding AG Lyme Disease Testing Product Portfolio Table 43. Roche Holding AG Recent Development Table 44. Fujirebio(H.U. Group Holdings) Company Information Table 45. Fujirebio(H.U. Group Holdings) Business Overview Table 46. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product Portfolio Table 48. Fujirebio(H.U. Group Holdings) Recent Development Table 49. ZEUS Scientific Company Information Table 50. ZEUS Scientific Business Overview Table 51. ZEUS Scientific Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. ZEUS Scientific Lyme Disease Testing Product Portfolio Table 53. ZEUS Scientific Recent Development Table 54. IGeneX Company Information Table 55. IGeneX Business Overview Table 56. IGeneX Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. IGeneX Lyme Disease Testing Product Portfolio Table 58. IGeneX Recent Development Table 59. Thermo Fisher Scientific Company Information Table 60. Thermo Fisher Scientific Business Overview Table 61. Thermo Fisher Scientific Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Thermo Fisher Scientific Lyme Disease Testing Product Portfolio Table 63. Thermo Fisher Scientific Recent Development Table 64. Everlywell Company Information Table 65. Everlywell Business Overview Table 66. Everlywell Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Everlywell Lyme Disease Testing Product Portfolio Table 68. Everlywell Recent Development Table 69. Oxford Immunotec Global PLC(PerkinElmer) Company Information Table 70. Oxford Immunotec Global PLC(PerkinElmer) Business Overview Table 71. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product Portfolio Table 73. Oxford Immunotec Global PLC(PerkinElmer) Recent Development Table 74. BioMerieux Company Information Table 75. BioMerieux Business Overview Table 76. BioMerieux Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. BioMerieux Lyme Disease Testing Product Portfolio Table 78. BioMerieux Recent Development Table 79. Bio-Rad Laboratories Company Information Table 80. Bio-Rad Laboratories Business Overview Table 81. Bio-Rad Laboratories Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Bio-Rad Laboratories Lyme Disease Testing Product Portfolio Table 83. Bio-Rad Laboratories Recent Development Table 84. T2 Biosystems Company Information Table 85. T2 Biosystems Business Overview Table 86. T2 Biosystems Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. T2 Biosystems Lyme Disease Testing Product Portfolio Table 88. T2 Biosystems Recent Development Table 89. North America Lyme Disease Testing Market Size by Type (2021-2026) & (US$ Million) Table 90. North America Lyme Disease Testing Market Size by Type (2027-2032) & (US$ Million) Table 91. North America Lyme Disease Testing Market Size by Application (2021-2026) & (US$ Million) Table 92. North America Lyme Disease Testing Market Size by Application (2027-2032) & (US$ Million) Table 93. North America Lyme Disease Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Lyme Disease Testing Market Size by Country (2021-2026) Table 95. North America Lyme Disease Testing Market Size by Country (2027-2032) Table 96. Europe Lyme Disease Testing Market Size by Type (2021-2026) & (US$ Million) Table 97. Europe Lyme Disease Testing Market Size by Type (2027-2032) & (US$ Million) Table 98. Europe Lyme Disease Testing Market Size by Application (2021-2026) & (US$ Million) Table 99. Europe Lyme Disease Testing Market Size by Application (2027-2032) & (US$ Million) Table 100. Europe Lyme Disease Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Lyme Disease Testing Market Size by Country (2021-2026) Table 102. Europe Lyme Disease Testing Market Size by Country (2027-2032) Table 103. China Lyme Disease Testing Market Size by Type (2021-2026) & (US$ Million) Table 104. China Lyme Disease Testing Market Size by Type (2027-2032) & (US$ Million) Table 105. China Lyme Disease Testing Market Size by Application (2021-2026) & (US$ Million) Table 106. China Lyme Disease Testing Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Lyme Disease Testing Market Size by Type (2021-2026) & (US$ Million) Table 108. Asia Lyme Disease Testing Market Size by Type (2027-2032) & (US$ Million) Table 109. Asia Lyme Disease Testing Market Size by Application (2021-2026) & (US$ Million) Table 110. Asia Lyme Disease Testing Market Size by Application (2027-2032) & (US$ Million) Table 111. Asia Lyme Disease Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Asia Lyme Disease Testing Market Size by Country (2021-2026) Table 113. Asia Lyme Disease Testing Market Size by Country (2027-2032) Table 114. South America, Middle East & Africa Lyme Disease Testing Market Size by Type (2021-2026) & (US$ Million) Table 115. South America, Middle East & Africa Lyme Disease Testing Market Size by Type (2027-2032) & (US$ Million) Table 116. South America, Middle East & Africa Lyme Disease Testing Market Size by Application (2021-2026) & (US$ Million) Table 117. South America, Middle East & Africa Lyme Disease Testing Market Size by Application (2027-2032) & (US$ Million) Table 118. South America, Middle East & Africa Lyme Disease Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. South America, Middle East & Africa Lyme Disease Testing Market Size by Country (2021-2026) Table 120. South America, Middle East & Africa Lyme Disease Testing Market Size by Country (2027-2032) Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Lyme Disease Testing Product Image Figure 2. Global Lyme Disease Testing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Lyme Disease Testing Market Share by Type: 2025 VS 2032 Figure 4. ELISA Image Figure 5. Western Blotting Image Figure 6. PCR Image Figure 7. Others Image Figure 8. Global Lyme Disease Testing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Lyme Disease Testing Market Share by Application: 2025 VS 2032 Figure 10. Hospital and Testing Agency Image Figure 11. Personal Image Figure 12. Global Lyme Disease Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 14. Global Lyme Disease Testing Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Lyme Disease Testing Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Lyme Disease Testing Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Lyme Disease Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Lyme Disease Testing Revenue Market Share by Type (2021-2032) Figure 21. Global Lyme Disease Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Lyme Disease Testing Revenue Market Share by Application (2021-2032) Figure 23. North America Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 24. North America Lyme Disease Testing Market Share by Type (2021-2032) Figure 25. North America Lyme Disease Testing Market Share by Application (2021-2032) Figure 26. North America Lyme Disease Testing Market Share by Country (2021-2032) Figure 27. United States Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 28. Canada Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 30. Europe Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 31. Europe Lyme Disease Testing Market Share by Type (2021-2032) Figure 32. Europe Lyme Disease Testing Market Share by Application (2021-2032) Figure 33. Europe Lyme Disease Testing Market Share by Country (2021-2032) Figure 34. Germany Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 35. France Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 37. Italy Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 38. Russia Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 40. China Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 41. China Lyme Disease Testing Market Share by Type (2021-2032) Figure 42. China Lyme Disease Testing Market Share by Application (2021-2032) Figure 43. Asia Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 44. Asia Lyme Disease Testing Market Share by Type (2021-2032) Figure 45. Asia Lyme Disease Testing Market Share by Application (2021-2032) Figure 46. Asia Lyme Disease Testing Market Share by Country (2021-2032) Figure 47. Japan Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 51. India Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 52. Australia Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Lyme Disease Testing Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Lyme Disease Testing Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Lyme Disease Testing Market Share by Country (2021-2032) Figure 57. Brazil Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 62. UAE Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 64. Chile Lyme Disease Testing Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • ELISA
  • Western Blotting
  • PCR
  • Others
Applications
  • Hospital and Testing Agency
  • Personal
Companies covered
  • Quidel Corporation
  • Roche Holding AG
  • Fujirebio(H.U. Group Holdings)
  • ZEUS Scientific
  • IGeneX
  • Thermo Fisher Scientific
  • Everlywell
  • Oxford Immunotec Global PLC(PerkinElmer)
  • BioMerieux
  • Bio-Rad Laboratories
  • T2 Biosystems

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Lyme Disease Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 ELISA
  5. 1.2.3 Western Blotting
  6. 1.2.4 PCR
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Lyme Disease Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital and Testing Agency
  11. 1.3.3 Personal
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Lyme Disease Testing Growth Trends by Region
  14. 1.5.1 Global Lyme Disease Testing Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Lyme Disease Testing Market Size by Region (2021-2026)
  16. 1.5.3 Lyme Disease Testing Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Lyme Disease Testing Market Dynamics
  1. 2.1 Lyme Disease Testing Industry Trends
  2. 2.2 Lyme Disease Testing Industry Drivers
  3. 2.3 Lyme Disease Testing Industry Opportunities and Challenges
  4. 2.4 Lyme Disease Testing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Lyme Disease Testing Revenue by Company (2021-2026)
  2. 3.2 Global Lyme Disease Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Lyme Disease Testing Key Company Head office and Area Served
  4. 3.4 Global Lyme Disease Testing Company, Product Type & Application
  5. 3.5 Global Lyme Disease Testing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Lyme Disease Testing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Lyme Disease Testing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Lyme Disease Testing Tier 1, Tier 2, and Tier 3
4 Lyme Disease Testing Market by Type
  1. 4.1 Global Lyme Disease Testing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Lyme Disease Testing Market Size by Type (2021-2032)
  3. 4.3 Global Lyme Disease Testing Market Size Share by Type (2021-2032)
5 Lyme Disease Testing Market by Application
  1. 5.1 Global Lyme Disease Testing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Lyme Disease Testing Market Size by Application (2021-2032)
  3. 5.3 Global Lyme Disease Testing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Quidel Corporation
  2. 6.1.1 Quidel Corporation Company Information
  3. 6.1.2 Quidel Corporation Business Overview
  4. 6.1.3 Quidel Corporation Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Quidel Corporation Lyme Disease Testing Product Portfolio
  6. 6.1.5 Quidel Corporation Recent Developments
  7. 6.2 Roche Holding AG
  8. 6.2.1 Roche Holding AG Company Information
  9. 6.2.2 Roche Holding AG Business Overview
  10. 6.2.3 Roche Holding AG Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Roche Holding AG Lyme Disease Testing Product Portfolio
  12. 6.2.5 Roche Holding AG Recent Developments
  13. 6.3 Fujirebio(H.U. Group Holdings)
  14. 6.3.1 Fujirebio(H.U. Group Holdings) Company Information
  15. 6.3.2 Fujirebio(H.U. Group Holdings) Business Overview
  16. 6.3.3 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product Portfolio
  18. 6.3.5 Fujirebio(H.U. Group Holdings) Recent Developments
  19. 6.4 ZEUS Scientific
  20. 6.4.1 ZEUS Scientific Company Information
  21. 6.4.2 ZEUS Scientific Business Overview
  22. 6.4.3 ZEUS Scientific Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 ZEUS Scientific Lyme Disease Testing Product Portfolio
  24. 6.4.5 ZEUS Scientific Recent Developments
  25. 6.5 IGeneX
  26. 6.5.1 IGeneX Company Information
  27. 6.5.2 IGeneX Business Overview
  28. 6.5.3 IGeneX Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 IGeneX Lyme Disease Testing Product Portfolio
  30. 6.5.5 IGeneX Recent Developments
  31. 6.6 Thermo Fisher Scientific
  32. 6.6.1 Thermo Fisher Scientific Company Information
  33. 6.6.2 Thermo Fisher Scientific Business Overview
  34. 6.6.3 Thermo Fisher Scientific Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Thermo Fisher Scientific Lyme Disease Testing Product Portfolio
  36. 6.6.5 Thermo Fisher Scientific Recent Developments
  37. 6.7 Everlywell
  38. 6.7.1 Everlywell Company Information
  39. 6.7.2 Everlywell Business Overview
  40. 6.7.3 Everlywell Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Everlywell Lyme Disease Testing Product Portfolio
  42. 6.7.5 Everlywell Recent Developments
  43. 6.8 Oxford Immunotec Global PLC(PerkinElmer)
  44. 6.8.1 Oxford Immunotec Global PLC(PerkinElmer) Company Information
  45. 6.8.2 Oxford Immunotec Global PLC(PerkinElmer) Business Overview
  46. 6.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product Portfolio
  48. 6.8.5 Oxford Immunotec Global PLC(PerkinElmer) Recent Developments
  49. 6.9 BioMerieux
  50. 6.9.1 BioMerieux Company Information
  51. 6.9.2 BioMerieux Business Overview
  52. 6.9.3 BioMerieux Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 BioMerieux Lyme Disease Testing Product Portfolio
  54. 6.9.5 BioMerieux Recent Developments
  55. 6.10 Bio-Rad Laboratories
  56. 6.10.1 Bio-Rad Laboratories Company Information
  57. 6.10.2 Bio-Rad Laboratories Business Overview
  58. 6.10.3 Bio-Rad Laboratories Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Bio-Rad Laboratories Lyme Disease Testing Product Portfolio
  60. 6.10.5 Bio-Rad Laboratories Recent Developments
  61. 6.11 T2 Biosystems
  62. 6.11.1 T2 Biosystems Company Information
  63. 6.11.2 T2 Biosystems Business Overview
  64. 6.11.3 T2 Biosystems Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 T2 Biosystems Lyme Disease Testing Product Portfolio
  66. 6.11.5 T2 Biosystems Recent Developments
7 North America
  1. 7.1 North America Lyme Disease Testing Market Size (2021-2032)
  2. 7.2 North America Lyme Disease Testing Market Size by Type
  3. 7.2.1 North America Lyme Disease Testing Market Size by Type (2021-2026)
  4. 7.2.2 North America Lyme Disease Testing Market Size by Type (2027-2032)
  5. 7.2.3 North America Lyme Disease Testing Market Share by Type (2021-2032)
  6. 7.3 North America Lyme Disease Testing Market Size by Application
  7. 7.3.1 North America Lyme Disease Testing Market Size by Application (2021-2026)
  8. 7.3.2 North America Lyme Disease Testing Market Size by Application (2027-2032)
  9. 7.3.3 North America Lyme Disease Testing Market Share by Application (2021-2032)
  10. 7.4 North America Lyme Disease Testing Market Size by Country
  11. 7.4.1 North America Lyme Disease Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Lyme Disease Testing Market Size by Country (2021-2026)
  13. 7.4.3 North America Lyme Disease Testing Market Size by Country (2027-2032)
  14. 7.4.4 North America Lyme Disease Testing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Lyme Disease Testing Market Size (2021-2032)
  2. 8.2 Europe Lyme Disease Testing Market Size by Type
  3. 8.2.1 Europe Lyme Disease Testing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Lyme Disease Testing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Lyme Disease Testing Market Share by Type (2021-2032)
  6. 8.3 Europe Lyme Disease Testing Market Size by Application
  7. 8.3.1 Europe Lyme Disease Testing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Lyme Disease Testing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Lyme Disease Testing Market Share by Application (2021-2032)
  10. 8.4 Europe Lyme Disease Testing Market Size by Country
  11. 8.4.1 Europe Lyme Disease Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Lyme Disease Testing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Lyme Disease Testing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Lyme Disease Testing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Lyme Disease Testing Market Size (2021-2032)
  2. 9.2 China Lyme Disease Testing Market Size by Type
  3. 9.2.1 China Lyme Disease Testing Market Size by Type (2021-2026)
  4. 9.2.2 China Lyme Disease Testing Market Size by Type (2027-2032)
  5. 9.2.3 China Lyme Disease Testing Market Share by Type (2021-2032)
  6. 9.3 China Lyme Disease Testing Market Size by Application
  7. 9.3.1 China Lyme Disease Testing Market Size by Application (2021-2026)
  8. 9.3.2 China Lyme Disease Testing Market Size by Application (2027-2032)
  9. 9.3.3 China Lyme Disease Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Lyme Disease Testing Market Size (2021-2032)
  2. 10.2 Asia Lyme Disease Testing Market Size by Type
  3. 10.2.1 Asia Lyme Disease Testing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Lyme Disease Testing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Lyme Disease Testing Market Share by Type (2021-2032)
  6. 10.3 Asia Lyme Disease Testing Market Size by Application
  7. 10.3.1 Asia Lyme Disease Testing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Lyme Disease Testing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Lyme Disease Testing Market Share by Application (2021-2032)
  10. 10.4 Asia Lyme Disease Testing Market Size by Country
  11. 10.4.1 Asia Lyme Disease Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Lyme Disease Testing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Lyme Disease Testing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Lyme Disease Testing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Lyme Disease Testing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Lyme Disease Testing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Lyme Disease Testing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Lyme Disease Testing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Lyme Disease Testing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Lyme Disease Testing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Lyme Disease Testing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Lyme Disease Testing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Lyme Disease Testing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Lyme Disease Testing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Lyme Disease Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Lyme Disease Testing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Lyme Disease Testing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Lyme Disease Testing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst